Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diabetic nephropathy]

D Garceau1, M Turgeon, S Gagnon

  • 1Hôpital Lava.

Canadian Family Physician Medecin De Famille Canadien
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

Diabetic nephropathy affects both Type I and Type II diabetes patients, with high morbidity and mortality. This study details the natural history and treatments for diabetic nephropathy, focusing on Type II diabetes progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Towards REPO<sub>4</sub> nanocrystal-doped optical fibers for distributed sensing applications.

Scientific reports·2023
Same author

The EEG correlates and dangerous behavioral consequences of drowsy driving after a single night of mild sleep deprivation.

Physiology & behavior·2022
Same author

Driving safety improves after individualized training: An RCT involving older drivers in an urban area.

Traffic injury prevention·2019
Same author

Effects of cue manipulation on performance by old and young rats in a test of non-matching-to-sample.

Behavioural processes·2014
Same author

Domain-specific cognitive effects of tramiprosate in patients with mild to moderate Alzheimer's disease: ADAS-cog subscale results from the Alphase Study.

The journal of nutrition, health & aging·2009
Same author

Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study.

The journal of nutrition, health & aging·2009
Same journal

Impact of virtual case conferences between primary care clinicians and an interdisciplinary chronic pain clinic.

Canadian family physician Medecin de famille canadien·2026
Same journal

Canadian family physician Medecin de famille canadien·2026
Same journal

Predictors of high-performing family medicine clinics: Prospective cohort study in Alberta.

Canadian family physician Medecin de famille canadien·2026
Same journal

Acetylsalicylic acid use for artial fibrillation and bleeding risk.

Canadian family physician Medecin de famille canadien·2026
Same journal

Clinical practice guidelines: Important tools to teach the art of medicine.

Canadian family physician Medecin de famille canadien·2026
Same journal

Paratonia in advanced dementia: Challenges and evidence-based interventions.

Canadian family physician Medecin de famille canadien·2026
See all related articles

Area of Science:

  • Nephrology
  • Endocrinology
  • Diabetology

Context:

  • Diabetic nephropathy presents significant morbidity and mortality risks in both Type I and Type II diabetes mellitus.
  • The progression and stages of diabetic nephropathy are well-characterized in Type I diabetes but less understood in Type II diabetes.

Purpose:

  • To examine the natural history of diabetic nephropathy in Type II diabetes.
  • To compare the characteristics and progression of diabetic nephropathy between Type I and Type II diabetes.
  • To review recommended treatments for diabetic nephropathy, considering type-specific factors.

Summary:

  • This review elucidates the natural history of diabetic nephropathy, particularly in Type II diabetes, contrasting it with the established progression in Type I diabetes.

Related Experiment Videos

  • It highlights key differences in the manifestation and progression of kidney disease between the two diabetes types.
  • Treatment strategies are discussed with an emphasis on tailoring interventions to the specific characteristics of Type I and Type II diabetic nephropathy.

    • Impact:

    • Improved understanding of Type II diabetic nephropathy progression can lead to earlier diagnosis and intervention.
    • Differentiating characteristics between Type I and Type II diabetic nephropathy may inform more personalized treatment approaches.
    • Addressing the knowledge gap in Type II diabetic nephropathy can potentially reduce associated morbidity and mortality rates.